Clinical Trial Update: Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases [NA]

View source ↗

Summary

A pilot trial is evaluating patient experience with the MemorEM device in several neurological diseases, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Corticobasal Degeneration
• Frontotemporal Dementia
• Parkinson Disease
• Posterior Cortical Atrophy

Drugs mentioned

• MemorEM

Snippet

Sponsor: NeuroEM Therapeutics, Inc. | Conditions: Alzheimer's Disease, Fronto-temporal Dementia | NA | Status: ENROLLING_BY_INVITATION